418,419,420 Dalbavancin (Xydalba ), a second-generation, semi-synthetic lipoglycopeptide antibiotic, has strong antibacterial activity against a variety of gram-positive bacteria (including methicillin-resistant Staphylococcus aureus MRSA and Streptococcus pyogenes) and some streptococci, with a long half-life and good tolerance
Subsequent release from adipose tissue can result in maintained cannabinoid activity for weeks after administration
The GLP-1 story illustrates a classic healthcare pattern: clinical innovation races ahead, while distribution, pricing, and regulation must catch up
This calculator uses 3.7V nominal cell voltage and common LiPo C-rate math to estimate pack energy and discharge capability
This means you would only need to pay the NHS prescription charge instead of the full price of your medication